Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
| Autor: | de Boer, S.M. *, Wortman, B.G., Bosse, T., Powell, M.E., Singh, N., Hollema, H., Wilson, G., Chowdhury, M.N., Mileshkin, L., Pyman, J., Katsaros, D., Carinelli, S., Fyles, A., McLachlin, C.M., Haie-Meder, C., Duvillard, P., Nout, R.A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L., Smit, V.T.H.B.M. |
|---|---|
| Zdroj: | In Annals of Oncology February 2018 29(2):424-430 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|